{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:12:20Z","timestamp":1770973940102,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.drugalcdep.2005.02.009","type":"journal-article","created":{"date-parts":[[2005,5,18]],"date-time":"2005-05-18T12:01:08Z","timestamp":1116417668000},"page":"351-357","source":"Crossref","is-referenced-by-count":64,"title":["Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants"],"prefix":"10.1016","volume":"79","author":[{"given":"Gary K.","family":"Hulse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Tait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra D.","family":"Comer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian G.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Arnold-Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2005.02.009_bib1","unstructured":"American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders\u2014IV Edition. APA, Washington."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0376-8716(81)90110-1","article-title":"Multiple family therapy and naltrexone in the treatment of opiate-dependence","volume":"8","author":"Anton","year":"1981","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib3","unstructured":"Australian Bureau of Statistics, 2002. Deaths Australia. Australian Bureau of Statistics, CGPS, catalogue no. 3302.0, Canberra."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5694\/j.1326-5377.1999.tb123493.x","article-title":"A pilot study of naltrexone-accelerated detoxification in opioid dependence","volume":"171","author":"Bell","year":"1999","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib5","first-page":"260","article-title":"Naltrexone implants for opiate addiction: new life for a middle aged drug","volume":"267","author":"Brewer","year":"2001","journal-title":"Pharm. J."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/13556210220139541","article-title":"Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases","volume":"7","author":"Brewer","year":"2002","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10826088009040057","article-title":"The treatment of heroin addiction using naltrexone alone and with behaviour therapy","volume":"15","author":"Callaghan","year":"1980","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1353-1131(96)90012-7","article-title":"The Singapore naltrexone community-based project for heroin addicts compared with drugfree community-based program: the first cohort","volume":"3","author":"Chan","year":"1996","journal-title":"J. Clin. Forensic Med."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib9","series-title":"APSAD 2004 National Conference: Beyond the Drug","article-title":"Effectiveness of an injectable, 30 day, sustained-release, depot formulation of naltrexone in the treatment of opioid dependence","author":"Comer","year":"2004"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002130100909","article-title":"Depot naltrexone: long-lasting antagonism of the effects of heroin in humans","volume":"159","author":"Comer","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09595239996743","article-title":"Heroin-related deaths in South Western Sydney Australia 1992\u201396","volume":"18","author":"Darke","year":"1999","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1360-0443.1996.tb02290.x","article-title":"Overdose among heroin users in Sydney Australia: II. Responses to overdose","volume":"91","author":"Darke","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0376-8716(97)00070-7","article-title":"A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney Australia","volume":"47","author":"Darke","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1360-0443.2000.9556874.x","article-title":"Cognitive impairment among methadone maintenance patients","volume":"95","author":"Darke","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0376-8716(00)00128-9","article-title":"Heroin-related deaths in Victoria: a review of cases for 1997 and 1998","volume":"61","author":"Gerostamoulos","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1553-2712.2002.tb01169.x","article-title":"Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets","volume":"9","author":"Hamilton","year":"2002","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib17","series-title":"An Information Document on the Current State of Research on Illicit Drugs in Australia","author":"Hando","year":"1998"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1467-842X.1999.tb01297.x","article-title":"Population-based linkage of health records in Western Australia: development of a health services research linked database","volume":"23","author":"Holman","year":"1999","journal-title":"Aust. N.Z. J. Pub. Health"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/09595230096138","article-title":"The association between naltrexone compliance and daily supervision","volume":"19","author":"Hulse","year":"2000","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/13556210310001602257","article-title":"A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in \u2018high risk\u2019 adolescent heroin users","volume":"8","author":"Hulse","year":"2003","journal-title":"Addict Biol."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1360-0443.1999.9422216.x","article-title":"The quantification of mortality resulting from the regular use of illicit opiates","volume":"94","author":"Hulse","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13556210410001674103","article-title":"Blood naltrexone and 6-b-naltrexol levels following naltrexone implant: comparing two naltrexone implants","volume":"9","author":"Hulse","year":"2004","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib23","volume":"vol. 9","author":"Julius","year":"1976"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib24","doi-asserted-by":"crossref","unstructured":"Kirchmayer, U., Davoli, M., Verster, A., 2002. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Systemic Rev CD001333 (2) (2002).","DOI":"10.1002\/14651858.CD001333"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09595230410001704118","article-title":"Impact of the heroin \u2018drought\u2019 on patterns of drug use and drug-related harms","volume":"23","author":"Longo","year":"2004","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1360-0443.1998.9357016.x","article-title":"Experience of non-fatal overdose among heroin users in delaide Australia\u2014circumstances and risk perceptions","volume":"93","author":"McGregor","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib27","first-page":"536","article-title":"Death as a complication of ultrarapid opiod detoxification (UROD)","volume":"38","author":"Olmedo","year":"2000","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1553-2712.2002.tb02199.x","article-title":"Rapid opiate detoxification in Australia (letter to editor)","volume":"9","author":"O\u2019Neil","year":"2002","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1360-0443.1991.tb01859.x","article-title":"Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts","volume":"86","author":"San","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib30","first-page":"42","article-title":"Clinical experience with naltrexone in suburban opioid addicts","volume":"45","author":"Tennant","year":"1984","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cpt1976203315","article-title":"Naltrexone: disposition, metabolism, and effects after acute and chronic dosing","volume":"20","author":"Verebey","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1360-0443.2002.00132.x","article-title":"Morbidity associated with non-fatal heroin overdose","volume":"97","author":"Warner-Smith","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0160-3450(16)31736-6","article-title":"Narcotic antagonists. An alternative for treating opioid dependence","volume":"NS22","author":"Willette","year":"1982","journal-title":"Am. Pharm."},{"key":"10.1016\/j.drugalcdep.2005.02.009_bib34","unstructured":"World Health Organization, 1992. International Classification of Diseases\u201410th Revision. WHO, Geneva."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871605000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871605000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T10:43:44Z","timestamp":1586256224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871605000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0376871605000967"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.02.009","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}